18 June 2025

We were delighted with a strong attendance of investors at our Health & Life Sciences pitch event last week – thanks to all who joined us and the founders presenting the 5 businesses.

This sector is evolving at a rapid pace, offering great opportunities to engage with innovative founders at a critical stage. We featured growing businesses within MedTech, HealthTech, FemTech, AI, CareTech and FinTech.

Our PACP sector specialist partners Dr Gopa Nair, Sharon O’Connor and Muna Khan are thrilled to share details of these businesses and investment opportunities, having worked closely with the founding teams in preparation for these funding rounds.

Investors interested to find out more, request an investor deck and arrange to meet with the founders, please contact the PACP partner highlighted for each of the opportunities detailed below:


Calla Lily

  • A pioneering British women’s health startup that has developed a proprietary platform for intravaginal drug delivery. Seeking to offer the world’s first drug-device combo product to help prevent miscarriages and for IVF luteal phase support.
  • Founders: Lara Zibners Lohr and Thang Vo-Ta
  • Sector: FemTech/MedTech
  • Stage: Pre-Series A
  • Raise: £2m EIS eligible
  • PACP Partner Contact: sharon@pa-capitalpartners.com
  • $2.6m in grant funding to date (NIHR & Innovate UK).
  • Regulatory pathways confirmed with UK regulator (MHRA).
  • Advanced discussions with C-suites of potential pharmaceuticals.
  • Robust global patent portfolio in place.
  • FDA clearance of underlying consumer technology.
  • SOM ambitions in the region of $160 million.

Mojo Fertility

  • Aiming to revolutionise make fertility with AI, Mojo Fertility is aimed at people who cannot afford IVF, with a software solution to increase access to sperm testing and help men improve their own fertility.
  • Founder: Darren Goode
  • Sector: HealthTech
  • Stage: Pre-Series A
  • Raise: £2.2 million
  • PACP Partner Contact: sharon@pa-capitalpartners.com
  • Infertility is no longer a women’s problem, men make up 50% of the problem.
  • More men need to be able to access sperm testing.
  • 80% of men can improve their own fertility with lifestyle changes, clinical or hormone support, and therefore avoiding IVF entirely.
  • $650k revenues for 2024, +141% v last year.
  • 86% gross margins.
  • $2.6m forecast for this year’s revenues, building to $140m by 2029.

SenLife

  • A revolutionary platform addressing the urgent and growing crisis in neurodivergence, empowering families, educators and clinicians, providing them with essential tools and insights, and significantly enhancing early diagnosis and intervention for conditions like Autism and ADHD.
  • Founders: Clare Newton, Jo Archer, Patrice Archer
  • Sector: HealthTech
  • Stage: Pre-Series A
  • Raise: £1m EIS/SEIS eligible
  • PACP Partner Contact: sharon@pa-capitalpartners.com
  • B2C web app has launched and is supporting 50 families as beta users.
  • Solutions have been co-designed with the NHS and leading educators.
  • B2B model is due to launch once funding is secured
  • Protected revenues for the UK are at least £5 million from 2026.
  • Global revenue opportunities in the region of £40 million annually.

Prorizon

  • Powered by AI and bioscience, a health and sports tech company tackling one of today’s biggest challenges – chronic stress and its damaging impact on human performance and health. On a mission to empower young people to thrive under pressure, starting with high-performance sports, where the need is urgent and the market is primed for innovation.
  • Founders: Prof Claire Stewart & Joly Zou
  • Sector: HealthTech
  • Stage: Pre-Seed
  • Raise: £650k (£90k SEIS still available)
  • PACP Partner Contact: muna@pa-capitalpartners.com
  • Starting in sports, its AI-powered, mind-body solution uniquely integrates mental, physical and social/environmental data into one intelligence system – delivering real-time, actionable insights for athletes and teams.
  • The founders are unlocking a scaleable opportunity to transform how stress, health and performance are managed across all high-pressure industries.
  • An IP protected solution bringing uniqueness to the market.
  • Revenue to date £25k (paid projects) with a current valuation of £3 million post-money, and a pipeline projection of £150k Q4 2025.

WemaCare

  • A digital platform dedicated to supporting unpaid informal carers and businesses in managing care responsibilities – where FinTech meets CareTech.
  • Founders: Vivek Patni, Rohit Patni, Rajal Patni
  • Sector: CareTech/FinTech
  • Stage: Seed
  • Raise: Min £500k EIS eligible
  • PACP Partner Contact: muna@pa-capitalpartners.com
  • Offering services such as care concierge, consultations and access to vetted social care providers, aiming to alleviate the pressures faced by working carers and enhance their wellbeing.
  • The platform integrates CQC-regulated care experts and AI technology to provide personalised support.
  • Businesses can incorporate WeMa into their employee benefits schemes, offering resources like 24/7 care information, training and dedicated care champions to assist employees with caregiving duties.
  • For individual carers, WeMa provides tailored support plans and assistance in navigating care options.
  • Pre-money valuation at £5 million with a projected ARR of £350k (yr 1) post funding.

 

Latest News

View All News